102 related articles for article (PubMed ID: 19995709)
21. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
[TBL] [Abstract][Full Text] [Related]
22. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
[TBL] [Abstract][Full Text] [Related]
23. Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.
Wipff J; Avouac J; Borderie D; Zerkak D; Lemarechal H; Kahan A; Boileau C; Allanore Y
Rheumatology (Oxford); 2008 Jul; 47(7):972-5. PubMed ID: 18477643
[TBL] [Abstract][Full Text] [Related]
24. A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.
McMeekin DS; Sill MW; Benbrook D; Darcy KM; Stearns-Kurosawa DJ; Eaton L; Yamada SD;
Gynecol Oncol; 2007 May; 105(2):508-16. PubMed ID: 17306350
[TBL] [Abstract][Full Text] [Related]
25. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.
Juraskova B; Andrys C; Holmerova I; Solichova D; Hrnciarikova D; Vankova H; Vasatko T; Krejsek J
J Nutr Health Aging; 2010 Nov; 14(9):758-61. PubMed ID: 21085906
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer.
Landt S; Mordelt K; Schwidde I; Barinoff J; Korlach S; Stöblen F; Lichtenegger W; Sehouli J; Kümmel S
Anticancer Res; 2011 Aug; 31(8):2651-5. PubMed ID: 21778318
[TBL] [Abstract][Full Text] [Related]
28. Endoglin (CD105) expression in endometrial carcinoma.
Saad RS; Jasnosz KM; Tung MY; Silverman JF
Int J Gynecol Pathol; 2003 Jul; 22(3):248-53. PubMed ID: 12819391
[TBL] [Abstract][Full Text] [Related]
29. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?
Schimming R; Reusch P; Kuschnierz J; Schmelzeisen R
J Craniomaxillofac Surg; 2004 Jun; 32(3):176-81. PubMed ID: 15113577
[TBL] [Abstract][Full Text] [Related]
30. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
Shariat SF; Anwuri VA; Lamb DJ; Shah NV; Wheeler TM; Slawin KM
J Clin Oncol; 2004 May; 22(9):1655-63. PubMed ID: 15117988
[TBL] [Abstract][Full Text] [Related]
31. A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease.
Fujimoto M; Hasegawa M; Hamaguchi Y; Komura K; Matsushita T; Yanaba K; Kodera M; Takehara K; Sato S
Dermatology; 2006; 213(2):88-92. PubMed ID: 16902284
[TBL] [Abstract][Full Text] [Related]
32. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).
Ojeda-Fernandez L; Barrios L; Rodriguez-Barbero A; Recio-Poveda L; Bernabeu C; Botella LM
Clin Chim Acta; 2010 Apr; 411(7-8):494-9. PubMed ID: 20067780
[TBL] [Abstract][Full Text] [Related]
33. Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy.
Motawi TK; Rizk SM; Ibrahim IA; El-Emady YF
Cell Biochem Funct; 2014 Mar; 32(2):155-63. PubMed ID: 23913471
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of VEGF levels in serums of colorectal cancer patients at stage IV].
Huang N; Yang L; Cao MR; Su N; Chen JZ; Lü CW; Liao WJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):278-9. PubMed ID: 19246299
[TBL] [Abstract][Full Text] [Related]
35. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
[TBL] [Abstract][Full Text] [Related]
36. Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage.
Strijbos MH; Rao C; Schmitz PI; Kraan J; Lamers CH; Sleijfer S; Terstappen LW; Gratama JW
Thromb Haemost; 2008 Oct; 100(4):642-7. PubMed ID: 18841287
[TBL] [Abstract][Full Text] [Related]
37. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
38. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
39. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
40. Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer.
Li C; Guo B; Wilson PB; Stewart A; Byrne G; Bundred N; Kumar S
Int J Cancer; 2000 Mar; 89(2):122-6. PubMed ID: 10754488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]